Eikon Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Millbrae, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eikon Therapeutics, Inc. has filed 57 SEC EDGAR filings since 13 May 2021

SEC filing history

Showing 1-25 of 57 matching filings.

Per page
25
Current page
1
3

3

Filing date
15 Jun 2026
Reporting date
15 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95483

SCHEDULE 13G filing

Filing date
15 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95483

SCHEDULE 13G filing

Filing date
13 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95483

SCHEDULE 13G filing

Filing date
06 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95483

SCHEDULE 13G filing

Filing date
29 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-43085

10-K

Filing date
30 Mar 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Mar 2026
Reporting date
02 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95483

SCHEDULE 13G filing

Filing date
18 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-95483

SCHEDULE 13D filing

Filing date
12 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95483

SCHEDULE 13G filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Feb 2026
Reporting date
06 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Feb 2026
Reporting date
06 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
06 Feb 2026
Reporting date
04 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Feb 2026
Reporting date
04 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .